Stocks and Investing Stocks and Investing
Tue, July 25, 2023

Michael Schmidt Maintained (SNDX) at Strong Buy with Increased Target to $42 on, Jul 25th, 2023


Published on 2024-10-28 05:06:24 - WOPRAI, Michael Schmidt
  Print publication without navigation


Michael Schmidt of Guggenheim, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $40 to $42 on, Jul 25th, 2023.

Michael has made no other calls on SNDX in the last 4 months.



There are 3 other peers that have a rating on SNDX. Out of the 3 peers that are also analyzing SNDX, 0 agree with Michael's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Michael


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $38 on, Monday, July 24th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $31 on, Wednesday, May 10th, 2023

Contributing Sources